Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Robert Ancuceanu, Mohammad‐Amin Abdollahifar et al.|The Lancet Public Health|2025Cited by 186
Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway RegulationReem Qannita, Yasser Bustanji, Ayah Alalami et al.|Pharmaceuticals|2024Cited by 101
Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023Quinn Rafferty, Reza Amani, Lauryn K Stafford et al.|The Lancet Global Health|2025Cited by 72
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit VaccinesSuhaila A. Al-Sheboul, Karem H. Alzoubi, Brent Brown et al.|Vaccines|2022Cited by 25
Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021Tissa Wijeratne, Yogesh Bahurupi, Jiyeon Oh et al.|Cell Reports Medicine|2025Cited by 16